Interview with Carlito Realuyo, President and General Manager, sanofi-aventis…
Mr. Realuyo, you have been in sanofi-aventis for 16 years, three of which were at the head. What have been the major achievements that the company has reached since your…
Address: 3F, Feliza Building, 108 V.A. Rufino St., Legaspi Village, 1229 Makati City,Philippines
Tel: +632 859-5555
Web: http://www.sanofi.ph/l/ph/en/index.jsp
A key player in the local pharmaceutical industry, sanofi-aventis Philippine is among the top five pharmaceutical companies in the Philippines. It is one of the largest affiliates of the sanofi-aventis Group in Southeast Asia, with a strong and dedicated workforce of about 700, all committed to the service of a cause that really matters… health.
The Philippine affiliate is driven by its mission to improve the quality of life and well-being of all its stakeholders by offering innovative medicines and vaccines, quality generics and consumer health products, delivered by highly empowered professionals who conduct business ethically, in partnership with the medical community.
To improve access to quality and affordable medicines to millions of Filipinos, sanofi-aventis Philippines launched its generics arm, Winthrop Pharmaceuticals Philippines, Inc., in October 2007.
Sanofi-aventis provides innovative therapeutic solutions to fight disease in seven major areas of expertise: thrombosis, cardiovascular diseases, diabetes, vaccines, oncology, central nervous system disorders and internal medicine.
It also holds strong position in consumer health and is strengthening the development of its generic product range.
Mr. Realuyo, you have been in sanofi-aventis for 16 years, three of which were at the head. What have been the major achievements that the company has reached since your…
Teodoro Padilla, Executive Director at the Pharmaceutical and Healthcare Association of the Philippines, and Reiner Gloor, Advisor and Honorary Member, discuss the current objectives and goals of the association, how they are…
The expansion of universal healthcare coverage and significant growth in the use and acceptance of generics across the Philippines pose a significant challenge to the innovative medicines industry but also…
“The IMS Health figures show around three to four percent growth in the marketplace,” remarks Raymund Azurin, chief executive of Zuellig Pharma Philippines, “but we are now at a…
Before the introduction of universal healthcare (UHC), most major private hospitals in the Philippines had to rely on imported products. With the MNCs showing only limited interest in small volumes,…
The inclusion of healthcare as a priority on the presidential agenda has led to knock-on consequences that are being felt across the healthcare value chain in the Philippines. Universal…
Kenneth Y Hartigan-Go, Acting Director General of the Food and Drug Administration Philippines (FDA) discusses the current state of regulations processes, strategies that the FDA are applying to the major…
Armando Esguerra, President of Chira Pharmaceuticals, Philippines, explains the concept of chirality, why it is relevant and extremely important in the pharmaceutical industry, and what have been the major challenges…
Raymund Azurin of Zuellig Group, Philippines, discusses the potential opportunities in the Philippines’ emerging healthcare sector, the affect of the increasing use of health apps and electronic health records, and…
Earl Stanley Perez, General Manager of Meyerf Philippines, explains the importance of focusing on a few niches to succeed in a growing in a competitive market such as the Philippines,…
Margarita Paz, Managing Director of Total Transcript Solutions (TTSI) Philippines, talks about the reason behind switching to the medical transcription business, despite her nursing degree, how this has become a…
Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in…
Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in…
See our Cookie Privacy Policy Here
